Menu
Back to User profile » Dr Kongying Lin
Papers published by Dr Kongying Lin:
Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study
Lin K, Wei F, Huang Q, Lai Z, Zhang J, Chen Q, Jiang Y, Kong J, Tang S, Lin J, Chen Y, Chen J, Zeng Y
Journal of Hepatocellular Carcinoma 2022, 9:127-140
Published Date: 8 March 2022
Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study
Huang Q, Lin K, Wang L, Zeng J, Liu H, Ding Z, Zeng Y, Liu J
Cancer Management and Research 2020, 12:9183-9195
Published Date: 28 September 2020
Development and Validation of a Prognostic Nomogram to Predict the Long-Time Prognosis in Non-B, Non-C Hepatocellular Carcinoma
Lin K, Huang Q, Huo Y, Zeng J, Ding Z, Guo P, Chen Z, Zeng Y, Liu J
Cancer Management and Research 2020, 12:7771-7781
Published Date: 24 August 2020
Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study
Zeng J, Lin K, Liu H, Huang Y, Guo P, Zeng Y, Zeng J, Liu J
Cancer Management and Research 2020, 12:6597-6606
Published Date: 30 July 2020
Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study
Wang L, Ke Q, Lin K, Chen J, Wang R, Xiao C, Liu X, Liu J
Cancer Management and Research 2020, 12:3815-3825
Published Date: 22 May 2020